Single User License: $2750
Member Price: FREE
Use code SUMMER at checkout for 50% OFF
Already a member? Login to access this report free.
Report Highlights
The global market for AI in genomics reached $498.6 million in 2021 and should reach more than $4.8 billion in 2027, with a compound annual growth rate (CAGR) of 47.3% during the forecast period of 2021-2027.
Report Includes
- 23 data tables and 19 additional tables
- An overview of the global market for artificial intelligence (AI) in genomics applications
- Analyses of the global market trends, with revenue data from 2020-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the current and future market potential for the AI genomics industry with an emphasis on new products and technologies, and areas of focus to forecast this market into various segments and sub-segments
- Evaluation and forecast the global AI genomics market size, and corresponding market share analysis by technology, offerings, application, and geographic region
- Technology assessment of the key drivers, restraints and opportunities that will shape the market for AI in genomics over the forecast period (2021 to 2027)
- In-depth information on major technology issues and challenges, government regulations, breakthrough innovations, collaborations and developments, and costs and benefits of AI applications in the genomics industry
- Review of recent industry trends, R&D activities, competitive landscape featuring key market participants, and COVID-19 implications within the AI genomics market ecosystem
- Company profiles of major players within the industry, including BenevolentAI, Data4Cure Inc., Deep Genomics, IBM Corp., and Microsoft Corp.
Report Scope
This report highlights the current and future market potential for AI genomics and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities, and trends in the market. The report also covers market projections through 2027 as well as key market players. BCC Research analyzes each technology in detail, determines major players and current market
status, and presents forecasts of growth over the next five years. Scientific challenges and advances, including the latest trends, are emphasized. Government regulations, major collaborations, recent patents, and factors affecting the industry from a global perspective are examined.
Key AI in genomics technologies and products are analyzed to determine present and future market status, and growth is forecast from 2022 to 2027. An in-depth discussion of strategic alliances, industry structures, competitive dynamics, patents, and market driving forces are also provided.
Report Synopsis
| Report Metrics | Details | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2021 | ||||||||||||
| Forecast period considered | 2022-2027 | ||||||||||||
| Base year market size | $498.6 million | ||||||||||||
| Market size forecast | $4.8 billion | ||||||||||||
| Growth rate | CAGR of 47.3% for the forecast period of 2022-2027 | ||||||||||||
| Units considered | $ Millions | ||||||||||||
| Segments covered | Offering, technology, application, and region | ||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) | ||||||||||||
| Key Market Drivers |
|
||||||||||||
| Companies studied |
|
||||||||||||
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets (HLC176E)
- Carbon Credits Market: Global Outlook (EGY200A)
- Drugs and Diagnostics for Hematological Disorders: Global Markets (PHM116C)
- Global Flame and Smoke Detectors Markets (MFG092A)
- Biodegradable Polymers: Global Markets and Technologies (PLS025K)
Related Reports
Global Markets for Artificial Intelligence in Drug Discovery
The global market for artificial intelligence (AI) in drug discovery is estimated to increase from $1.6 billion in 2023 to $5.7 billion by 2028, at a compound annual growth rate (CAGR) of 29.6% from 2023 through 2028.
Global Markets for Machine Learning in the Life Sciences
The global market for machine learning in the life sciences is estimated to increase from $3.2 billion in 2022 to reach $20.7 billion by 2027, at a compound annual growth rate (CAGR) of 45.5% from 2022 through 2027.
AI in Medical Diagnostics: Global Markets
The global market for AI medical diagnostics is estimated to increase from $748 million in 2021 to reach $4.0 billion by 2026, at a compound annual growth rate (CAGR) of 39.8% during the forecast period of 2021-2026.
Artificial Intelligence (AI) in Cancer
The goal of this short study is to provide a detailed review of how AI is being applied in fighting cancer. The report will evaluate the utilization of various AI tools (e.g., machine learning, natural language processing, image processing, speech recognition) in diagnosis, therapy, research and development, and health management (e.g., patient data, insurance information, and hospital stay) as it relates to cancer. Also, emphasis will be given to the types of algorithms (e.g., artificial neural networks, deep learning) that have been developed so far in the field of cancer.
Recent Reports
Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets
The global market for radiation therapy products and radiopharmaceuticals is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.
Routine Health Screening Market
The global market for routine health screening is expected to grow from $59.7 billion in 2024 and is projected to reach $82.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2029.
Elder Care Services and Assistive Devices: Global Markets
The global market for elder care services and assistive devices is expected to grow from $868.2 billion in 2024 and is projected to reach $1.1 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 5.8% during the forecast period of 2024 to 2029.
Direct-to-Consumer Testing Industry: Global Markets
The global market for direct-to-consumer (DTC) testing is estimated to increase from $1.6 billion in 2023 to reach $3.2 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.
Health and Medical Insurance Providers: Global Markets
The global market for health and medical insurance providers is expected to grow from $2.2 trillion in 2023 to $3.4 trillion by the end of 2028, at a compound annual growth rate (CAGR) of 8.9% during the forecast period of 2023 to 2028.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More